[The anti-arrythmic affect of a new beta-adrenergic blocking agent (H 56-28, Aptin). A study with the aid of continuing ECG-monitoring].
D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D013565:Sympatholytics / Q000627:therapeutic use*
D000605:Amino Alcohols; D013565:Sympatholytics
Den antiarytmiske effekt af et nyt beta-adrenergt blockerende medikament (H 56-28, Aptin). Undersogelser ved hjaelp af kontinuerlig ekgmonitorering.